Urine test outperforms MRI for monitoring low-risk prostate cancer in new study
The test, called MyProstateScore 2.0-Active Surveillance (MPS2-AS), was evaluated in over 300 patients on active surveillance for Grade Group (GG) 1 prostate cancer, according to lead author Jeffrey Tosoian, MD, MPH, assistant professor in the Department of Urology at Vanderbilt Health.
Source: Medical Xpress
